SEC Form 4 · accession 0001214659-17-005551
Anthera Pharmaceuticals Inc · ANTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul F Truex
Director
Period of report
Sep 7, 2017
Accepted (ET)
Sep 7, 2017 · 6:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001316175
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 7, 2017 | P | 5,000 | $1.34 | A | 16,793 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Reporting Person acquired the shares in the open market and through the 2005 Truex Family Trust u/d/t April 20, 2005. Shares have been adjusted to reflect the issuer's 1-for-8 reverse stock split effectuated on April 28, 2017.